Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODAFIMS
2022-501414-53-00Phase 2Authorised
- Sponsor
- Centro Clínico Académico - Braga
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of modafinil in multiple sclerosis (MS), sponsored by Centro Clínico Académico - Braga. Planned start Jun 2024; status: authorised.
02
Drugs
modafinil
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2022-501414-53-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501414-53-00.